跳至主要内容
临床试验/CTRI/2020/08/027370
CTRI/2020/08/027370尚未招募4 期

EFFICACY OF AYURVEDIC RASAYANA COMPOUND(IMMUNOMODULATION)IN AMAVATA WITH SPECIAL REFERENCE TO RHEUMATOID ARTHRITIS,AN OPEN RANDOMIZED COMPARATIVE CLINICAL TRIA

All India Institure of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Patients having the clinical manifestation of Amavata (RA) according to Ayurvedic classics
  • - SANDHISHOOL (PAIN), SHOTH (SWELLING), SPARSHASAHTA (TENDERNESS) and STABDHATA (STIFFNESS) Angamarda, Aruchi, Trishna, Alasya, Gaurava, Jwar , Apaka, Shoonataanganam, Agnidaurbalya, Praseka, Vairasya, Ruja, and Shotha in Hasta, Pada, Shiro, Gulpha, Trika, Janu, Uru Sandhi, VrishchikaDanshavataVedana,Vibandha, Nidra-Viparyaya, Daha, Bahumutrata
  • 2) Patients having positive RA factor.
  • 3) The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis Score.

排除标准

  • 1.Patients with other systemic complications of RA like RHD, Rheumatic fever, pleural â?? pericardial disease. Patients with poorly controlled Hypertension ( >160/100 mm of Hg).
  • 2.Patients diagnosed with other arthritis like gouty arthritis, tuberculous arthritis, etc.
  • 3.Patients who are unable to walk without support and / or confined to wheel chair.
  • 4.H/o hypersensitivity to any of the trial drugs or their ingredients.
  • 5.Pregnant / lactating woman.
  • 6.Patients who have completed participation in any other clinical trial during the past 6 months.

研究者

发起方
All India Institure of Ayurveda

相似试验